{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:39:03Z","timestamp":1792791543480,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019889","name":"Weston Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019889","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000064","name":"University of Toronto Banting & Best Diabetes Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["DDF"],"award-info":[{"award-number":["DDF"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017470","name":"Centre for Addiction and Mental Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017470","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.neuropharm.2026.111180","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T06:01:04Z","timestamp":1788760864000},"page":"111180","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protective effects of central leptin on whole-body energy homeostasis following acute olanzapine exposure"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9411-7426","authenticated-orcid":false,"given":"Raghunath","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Asgariroozbehani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3684-3539","authenticated-orcid":false,"given":"Ali Sajid","family":"Imami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul-rizaq","family":"Hamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Baranowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2721-4430","authenticated-orcid":false,"given":"Stewart","family":"Jeromson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Prevot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Mahavir","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Remington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3867-8901","authenticated-orcid":false,"given":"David C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adria","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-7150","authenticated-orcid":false,"given":"Robert E.","family":"Mccullumsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-4984","authenticated-orcid":false,"given":"Sandra","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret K.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.111180_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3390\/ijms27010168","article-title":"Leptin as a potential modifier of neuroinflammation: contrasting roles in alzheimer's disease and multiple sclerosis","volume":"27","author":"Abbasi Kasbi","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity"},{"key":"10.1016\/j.neuropharm.2026.111180_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111180_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/schbul\/sbq053","article-title":"Atypical antipsychotics rapidly and inappropriately switch peripheral fuel utilization to lipids, impairing metabolic flexibility in rodents","author":"Albaugh","year":"2012","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2026.111180_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1039\/C8MO00173A","article-title":"Kinase network dysregulation in a human induced pluripotent stem cell model of DISC1 schizophrenia","volume":"15","author":"Bentea","year":"2019","journal-title":"Mol. Omi."},{"key":"10.1016\/j.neuropharm.2026.111180_bib6","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects","volume":"31","author":"Boyda","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib7","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nm1775","article-title":"Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms","volume":"14","author":"Buettner","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2026.111180_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.pnpbp.2018.01.004","article-title":"Atypical antipsychotics, insulin resistance and weight; a meta-analysis of healthy volunteer studies","volume":"83","author":"Burghardt","year":"2018","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib9","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.33710","article-title":"POMC neurons expressing leptin receptors coordinate metabolic responses to fasting via suppression of leptin levels","volume":"7","author":"Caron","year":"2018","journal-title":"eLife"},{"key":"10.1016\/j.neuropharm.2026.111180_bib10","article-title":"Preclinical and clinical sex differences in antipsychotic-induced metabolic disturbances: a narrative review of adiposity and glucose metabolism","volume":"4","author":"Castellani","year":"2019","journal-title":"J. Psychiatry Brain Sci"},{"key":"10.1016\/j.neuropharm.2026.111180_bib11","first-page":"1","article-title":"Antipsychotics impair regulation of glucose metabolism by central glucose","author":"Castellani","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111180_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.psyneuen.2018.07.028","article-title":"Effects of acute olanzapine exposure on central insulin-mediated regulation of whole body fuel selection and feeding","volume":"98","author":"Castellani","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large scale meta analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib14","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/hep.32467","article-title":"Hepatic kinome atlas: an in\u2010depth identification of kinase pathways in liver fibrosis of humans and rodents","volume":"76","author":"Creeden","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib15","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1096\/fj.06-5989fje","article-title":"Leptin signaling in neurotensin neurons involves STAT, MAP kinases ERK1\/2, and p38 through c\u2010Fos and ATF1","volume":"20","author":"Cui","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.neuropharm.2026.111180_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2337\/diab.45.10.1446","article-title":"The weight-reducing effect of an intracerebroventricular bolus injection of Leptin in genetically obese fa\/fa rats: reduced sensitivity compared with lean animals","volume":"45","author":"Cusin","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111180_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2017.04.011","article-title":"The glucoregulatory actions of leptin","author":"D\u2019souza","year":"2017","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib18","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111180_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","author":"De Hert","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib20","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.2040-1124.2012.00203.x","article-title":"The role of leptin in glucose homeostasis","volume":"3","author":"Denroche","year":"2012","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.neuropharm.2026.111180_bib21","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/db10-0958","article-title":"Leptin therapy reverses hyperglycemia in mice with streptozotocin-induced diabetes, independent of hepatic leptin signaling","volume":"60","author":"Denroche","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111180_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0260440","article-title":"KRSA: an R package and R shiny web application for an end-to-end upstream kinase analysis of kinome array data","volume":"16","author":"DePasquale","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2026.111180_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01203-z","article-title":"Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?","volume":"19","author":"Endomba","year":"2020","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.neuropharm.2026.111180_bib24","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/jn\/133.9.2707","article-title":"Leptin and insulin modulate nutrient partitioning and weight loss in ob\/ob mice through regulation of long-chain fatty acid uptake by adipocytes","volume":"133","author":"Fan","year":"2003","journal-title":"J. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111180_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3389\/fphys.2018.00640","article-title":"Obesity, fat mass and immune system: role for Leptin","volume":"9","author":"Francisco","year":"2018","journal-title":"Front. Physiol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/ijo.2008.246","article-title":"Energy metabolism, fuel selection and body weight regulation","author":"Galgani","year":"2008","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.neuropharm.2026.111180_bib27","doi-asserted-by":"crossref","DOI":"10.2337\/db08-0043","article-title":"Metabolic flexibility in response to glucose is not impaired in people with type 2 diabetes after controlling for glucose disposal rate","author":"Galgani","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111180_bib28","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3389\/fimmu.2017.01507","article-title":"Reduced endoplasmic reticulum stress-mediated autophagy is required for leptin alleviating inflammation in adipose tissue","volume":"8","author":"Gan","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.euroneuro.2014.11.008","article-title":"Antipsychotics-induced metabolic alterations: focus on adipose tissue and molecular mechanisms","volume":"25","author":"Gon\u00e7alves","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib30","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/026988110201600402","article-title":"Characterization of olanzapine-induced weight gain in rats","volume":"16","author":"Goudie","year":"2002","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib31","doi-asserted-by":"crossref","DOI":"10.1530\/JOE-23-0308","article-title":"In vivo techniques for assessment of insulin sensitivity and glucose metabolism","volume":"260","author":"Hahn","year":"2024","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S2215-0366(25)00162-2","article-title":"Holistic prevention and management of physical health side-effects of psychotropic medication: second report of the <em>Lancet Psychiatry<\/em> Physical health commission","volume":"12","author":"Halstead","year":"2025","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2013.05.009","article-title":"Direct and indirect effects of leptin on adipocyte metabolism","author":"Harris","year":"2014","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2026.111180_bib34","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnab025","article-title":"Arcuate nucleus-dependent regulation of metabolism-pathways to obesity and diabetes mellitus","author":"Jais","year":"2022","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2026.111180_bib35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.5483\/BMBRep.2022.55.6.026","article-title":"Metformin ameliorates olanzapine-induced disturbances in POMC neuron number, axonal projection, and hypothalamic leptin resistance","volume":"55","author":"Kim","year":"2022","journal-title":"BMB Rep."},{"key":"10.1016\/j.neuropharm.2026.111180_bib36","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00213-009-1639-8","article-title":"Olanzapine-induced weight gain in the rat: role of 5-HT2C and histamine H1 receptors","volume":"207","author":"Kirk","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2026.111180_bib37","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/schbul\/sbs196","article-title":"Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL\/6J mice","volume":"40","author":"Klingerman","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neuropharm.2026.111180_bib38","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00164.2018","article-title":"Antipsychotics and glucose metabolism: how brain and body collide","volume":"316","author":"Kowalchuk","year":"2019","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.neuropharm.2026.111180_bib39","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1503\/jpn.170092","article-title":"In male rats, the ability of central insulin to suppress glucose production is impaired by olanzapine, whereas glucose uptake is left intact","volume":"42","author":"Kowalchuk","year":"2017","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib40","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1074\/mcp.TIR118.000943","article-title":"A curated resource for phosphosite-specific signature analysis","volume":"18","author":"Krug","year":"2019","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.neuropharm.2026.111180_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2020.146859","article-title":"Dual functions of CNS inflammation in food intake and metabolic regulation","volume":"1740","author":"Lee","year":"2020","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2026.111180_bib42","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1073\/pnas.96.12.7047","article-title":"Leptin actions on food intake and body temperature are mediated by IL-1","volume":"96","author":"Luheshi","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib43","article-title":"The glucose lowering effects of CL 316,243 dissipate with repeated use and are rescued by cilostamide","volume":"10","author":"Medak","year":"2022","journal-title":"Phys. Rep."},{"key":"10.1016\/j.neuropharm.2026.111180_bib44","first-page":"E1101","article-title":"GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia","volume":"319","author":"Medak","year":"2020","journal-title":"Am. J. Physiol. Metab."},{"key":"10.1016\/j.neuropharm.2026.111180_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2019.104413","article-title":"Female mice are protected against acute olanzapine-induced hyperglycemia","volume":"110","author":"Medak","year":"2019","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2008.12.004","article-title":"Leptin signaling in brain: a link between nutrition and cognition?","author":"Morrison","year":"2009","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.neuropharm.2026.111180_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.815456","article-title":"Understanding the effects of antipsychotics on appetite control","author":"Mukherjee","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.neuropharm.2026.111180_bib48","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.biopsych.2021.02.017","article-title":"Identification of novel neurocircuitry through which leptin targets multiple inputs to the dopamine system to reduce food reward seeking","volume":"90","author":"Omrani","year":"2021","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrn.2017.168","article-title":"Leptin and the maintenance of elevated body weight","volume":"19","author":"Pan","year":"2018","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib50","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2026.111180_bib51","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqad025","article-title":"Antipsychotic-induced alterations in lipid turnover","volume":"164","author":"Pereira","year":"2023","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2024.106987","article-title":"Olanzapine's effects on hypothalamic transcriptomics and kinase activity","volume":"163","author":"Pereira","year":"2024","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib53","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa027","article-title":"Tissue-Specific effects of leptin on glucose and lipid metabolism","author":"Pereira","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.neuropharm.2026.111180_bib54","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2215-0366(19)30416-X","article-title":"Comparative effects of 18 antipsychotics on metabolic function in patients with schizophrenia, predictors of metabolic dysregulation, and association with psychopathology: a systematic review and network meta-analysis","volume":"7","author":"Pillinger","year":"2020","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib55","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.111180_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0091-3057(03)00042-X","article-title":"Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human","volume":"75","author":"Pouzet","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2026.111180_bib57","first-page":"E225","article-title":"Dispensed prescriptions for quetiapine and other second-generation antipsychotics in Canada from 2005 to 2012: a descriptive study. C","volume":"2","author":"Pringsheim","year":"2014","journal-title":"Open"},{"key":"10.1016\/j.neuropharm.2026.111180_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2631","article-title":"Association between antipsychotic treatment and leptin levels across multiple psychiatric populations: an updated meta-analysis","volume":"32","author":"Ragguett","year":"2017","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.pharmthera.2009.10.010","article-title":"Metabolic side effects of antipsychotic drug treatment - pharmacological mechanisms","volume":"125","author":"Reynolds","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2026.111180_bib60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.npep.2015.04.001","article-title":"Effect of short and long-term treatment with antipsychotics on orexigenic\/anorexigenic neuropeptides expression in the rat hypothalamus","volume":"51","author":"Rojczyk","year":"2015","journal-title":"Neuropeptides"},{"key":"10.1016\/j.neuropharm.2026.111180_bib61","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1124\/jpet.113.207621","article-title":"Olanzapine activates hepatic mammalian target of rapamycin: new mechanistic insight into metabolic dysregulation with atypical antipsychotic drugs","volume":"347","author":"Schmidt","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.111180_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/20451253221096525","article-title":"Gut microbiome in schizophrenia and antipsychotic-induced metabolic alterations: a scoping review","volume":"12","author":"Singh","year":"2022","journal-title":"Ther. Adv. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.111180_bib63","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/acps.13365","article-title":"Adiposity in schizophrenia: a systematic review and meta\u2010analysis","volume":"144","author":"Smith","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2026.111180_bib64","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1001\/jamapsychiatry.2025.2240","article-title":"Antipsychotic drugs and dysregulated glucose homeostasis","volume":"82","author":"Smith","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.111180_bib65","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11920-023-01458-0","article-title":"Antipsychotic-induced weight gain in severe mental illness: risk factors and special considerations","volume":"25","author":"Stogios","year":"2023","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2026.111180_bib66","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","article-title":"Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis","volume":"47","author":"Stogios","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2015.09.026","article-title":"Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis","author":"Stubbs","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2026.111180_bib68","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neuropharm.2026.111180_bib69","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/153537020523000306","article-title":"Acute central infusion of leptin modulates fatty acid mobilization by affecting lipolysis and mRNA expression for uncoupling proteins","volume":"230","author":"Tajima","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.neuropharm.2026.111180_bib70","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.2337\/db12-1629","article-title":"Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle","volume":"62","author":"Toda","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111180_bib71","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0031-9384(98)00243-1","article-title":"Metabolic responses to intracerebroventricular leptin and restricted feeding","volume":"65","author":"Wang","year":"1998","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2026.111180_bib72","doi-asserted-by":"crossref","DOI":"10.1192\/bjpo.bp.116.002766","article-title":"Effectiveness of antipsychotics used in first-episode psychosis: a naturalistic cohort study","author":"Whale","year":"2016","journal-title":"BJPsych Open"},{"key":"10.1016\/j.neuropharm.2026.111180_bib73","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-018-0049-7","article-title":"Genetic identification of leptin neural circuits in energy and glucose homeostases","volume":"556","author":"Xu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2026.111180_bib74","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dbi19-0018","article-title":"Leptin: less is more","volume":"69","author":"Zhao","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.neuropharm.2026.111180_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade8460","article-title":"Hyperleptinemia contributes to antipsychotic drug\u2013associated obesity and metabolic disorders","volume":"15","author":"Zhao","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.neuropharm.2026.111180_bib76","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2010.05.009","article-title":"Pharmacology , biochemistry and behavior olanzapine affects locomotor activity and meal size in male rats","volume":"97","author":"Zwaal","year":"2010","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003552?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826003552?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:54:00Z","timestamp":1792788840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826003552"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":76,"alternative-id":["S0028390826003552"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111180","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effects of central leptin on whole-body energy homeostasis following acute olanzapine exposure","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.111180","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111180"}}